PDL BioPharma (PDLI) Tops Estimates

Shares of PDL BioPharma, Inc. (PDLI) rallied after the pharmaceutical firm released its earnings results on Monday. The company reported Q2 EPS/$0.52 vs $0.46 consensus on $163 million in revenue, up about 10% from $148.5 million a year ago. For the six month period ended June 30, 2014 the company saw revs increase by 23% […] View the full post at: PDL BioPharma (PDLI) Tops Estimates No related posts.